IDENTIFICATION OF NON-SMALL CELL LUNG CARCINOMA (NSCLC) TUMORS EXPRESSING PDGFR-ALPHA

The invention discloses a previously unidentified subset of mammalian non-small cell lung carcinomas (NSCLC) in which platelet-derived growth factor receptor alpha (PDGFRα) is expressed and is driving the disease, and provides methods for identifying a mammalian NSCLC tumor that belongs to a subset...

Full description

Saved in:
Bibliographic Details
Main Authors GUO, AILAN, CROSBY, KATHERINE, LEE, KIMBERLY, POLAKIEWICZ, ROBERTO, ZENG, QINGFU, RIKOVA, KLARISA
Format Patent
LanguageEnglish
French
German
Published 16.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses a previously unidentified subset of mammalian non-small cell lung carcinomas (NSCLC) in which platelet-derived growth factor receptor alpha (PDGFRα) is expressed and is driving the disease, and provides methods for identifying a mammalian NSCLC tumor that belongs to a subset of NSCLC tumors in which PDGFRα is expressed, and for identifying a NSCLC tumor that is likely to respond to a PDGFRα-inhibiting therapeutic. The invention also provides methods for inhibiting the progression of a mammalian NSCLC tumor in which PDGFRα is expressed, and for determining whether a compound inhibits the progression of a PDGFRα-expressing mammalian NSCLC tumor.
Bibliography:Application Number: EP20050768977